The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)
Filter results
| Date | Title | Content | |
|---|---|---|---|
| 27/11/2020 | On business and financial situation | The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia | |
| 24/11/2020 | On business and financial situation | The Company releases the presentation related to its strategy update because of the 2020 Capital Markets Day. | |
| 13/11/2020 | Other relevant information | The Company informs about the dividends payment | |
| 5/11/2020 | On business and financial situation | The company releases the press release related to the 2020 first nine months financial results | |
| 5/11/2020 | On business and financial situation | ROVI releases the 2020 First Nine Months Results presentation | |
| 20/10/2020 | Announcement of general shareholders’ meeting | ROVI releases the information related to its General Shareholders Meeting | |
| 15/10/2020 | Announcement of general shareholders’ meeting | In view of the exceptional circumstances derived from the spread of Covid-19, the Company has agreed that the Ordinary General Meeting be held by exclusively telematic means. | |
| 1/10/2020 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the third quarter of 2020 | |
| 11/09/2020 | Announcement of general shareholders’ meeting | Rovi releases the information related to its 2020 General Shareholders Meeting. | |
| 27/07/2020 | On business and financial situation | The company releases the press release related to the 2020 first half financial results |